No. PAR-25-281 · National Institutes of Health
Mood and Psychosis Symptoms during the Menopause Transition (R01 Clinical Trial Optional)
No audit required
“This NOFO does not require cost sharing as defined in the NIH Grants Policy Statement Section 1.2 Definition of Terms .” — From the announcement
Not reimbursement-only
“Grant: A financial assistance mechanism providing money, property, or both to an eligible entity to carry out an approved project or activity.” — From the announcement
- Award range
- Not specified
- Expected awards
- Not specified
- Application deadline
- Jan 7, 2028
- Posted
- Nov 22, 2024
- Last verified
- Yesterday
At a glance
AI summaryThis grant funds mechanistic and translational research on mood disruption and psychosis during the menopausal transition, including studies of underlying biology, behavior, and social factors, and it can also support mechanistic clinical trials. Eligible applicants include a wide range of U.S. and non-U.S. organizations, including nonprofits, universities, governments, small businesses, and foreign organizations, and foreign components of U.S. organizations are allowed. Award budgets are not limited, the project period can be up to 5 years, and no cost sharing is required. The notice says the number of awards depends on NIH appropriations and the quality of applications, and research must target people transitioning through menopause.
AI-generated summary — verify against the announcement
What it funds
Official description from grants.gov
The purpose of this Notice of Funding Opportunity (NOFO) is to advance translational research to better understand the emergence and worsening of mood and psychotic disorders (e.g., perimenopausal depression (PMD), generalized anxiety disorder, bipolar disorder and schizophrenia) during the menopause transition (MT) in an effort to identity targets for future development of novel treatment interventions. This funding opportunity aims to advance novel and innovative translational research to better comprehend the underlying neurobiological and behavioral mechanisms of mood and psychosis disorders and related symptoms during MT. This funding opportunity also encourages interdisciplinary researchers to collaborate on studies of mood and psychosis during the MT. Aspects of mood and psychosis disorders that are of interest include: classic depressive symptoms in combination with menopause symptoms (e.g., hot flashes, night sweats, sleep disturbance) and psychological challenges, the role of reproductive steroids in the regulation of mood and behavior during the MT, diagnosis of mood and psychosis symptoms at menopausal stage, investigation of co-occurring psychiatric and menopause symptoms, appreciation of psychosocial factors common in midlife, and differential diagnoses. Review criteria will focus on the comprehensiveness of the neurobiology and mechanisms of action underlying mood and psychosis symptoms and hypothesis-driven work.
Who can apply
- City or township governments
- County governments
- For-profit organizations other than small businesses
- Independent school districts
- Native American tribal governments (Federally recognized)
- Native American tribal organizations (other than Federally recognized)
- Nonprofits with 501(c)(3) status (other than higher education)
- Nonprofits without 501(c)(3) status (other than higher education)
- Others
- Private institutions of higher education
- Public and State controlled institutions of higher education
- Public housing authorities / Indian housing authorities
- Small businesses
- Special district governments
- State governments
Program history
USASpending.govAssistance listing 93.242 · Mental Health Research Grants
Real awards this federal program has made — the whole assistance listing (93.242), not just this notice.
| Fiscal year | Awards | Median award | Middle half |
|---|---|---|---|
| FY 2026 (so far) | 491 | $451,000 | $167,702 – $811,948 |
| FY 2025 | 600 | $731,738 | $320,544 – $1,460,736 |
| FY 2024 | 883 | — | — |
| FY 2023 | 898 | — | — |
| FY 2022 | 986 | — | — |
| FY 2021 | 945 | — | — |
Dollar figures are based on the 1,000 most recent awards we store, not all 4,803 — award counts are complete.
- MASSACHUSETTS INSTITUTE OF TECHNOLOGY $21,714,815 · FY 2025
- OHIO STATE UNIVERSITY, THE $19,515,757 · FY 2025
- ALBERT EINSTEIN COLLEGE OF MEDICINE $18,270,924 · FY 2025
- DUKE UNIVERSITY $15,039,330 · FY 2025
- ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI $12,007,972 · FY 2026
Source: USASpending.gov · refreshed Aug 6, 2026
Assistance listing 93.313 · NIH Office of Research on Women's Health
Real awards this federal program has made — the whole assistance listing (93.313), not just this notice.
No grants-family awards recorded for this program since FY 2021 — it may be new, renamed, or not yet reported to USASpending.
Source: USASpending.gov · refreshed Aug 30, 2026